Voloridge Investment Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Voloridge Investment Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-499,080	Closed	-$12M	–	1633
2023 Q1	$12M	Buy	499,080 +188,387	+61%	+$2.36M	0.06%	407
2022 Q4	$3.28M	Buy	+310,693	New	+$2.51M	0.02%	811

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Voloridge Investment Management's PRVB Position: Q2 2023 in Review

Voloridge Investment Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 499,080 shares — an estimated $12M sold.

Voloridge Investment Management first reported a position in PRVB in Q4 2022 and held it in 2 quarters. The position peaked at $12M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Voloridge Investment Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Voloridge Investment Management sold 499,080 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $12M.
Voloridge Investment Management first reported a position in Provention Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Voloridge Investment Management's Provention Bio, Inc. Common Stock position peaked at $12M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.